ETS-dependent regulation of a distal Gata4 cardiac enhancer

Developmental Biology

Volumn 361, Issue 2, 2012, Pages 439-449

  Schachterle, William ^a,b   Rojas, Anabel ^a   Xu, Shan Mei ^a   Black, Brian L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CABIMER Andalusian Center for Molecular Biology and Regenerative Medicine CSIC University of Seville UPO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ETS PROTEIN; ETS1 PROTEIN; ETV1 PROTEIN; ETV5 PROTEIN; FLI1 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ERG; TRANSCRIPTION FACTOR ETV6; TRANSCRIPTION FACTOR GATA 4; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; DEVELOPMENTAL STAGE; EMBRYO; EMBRYONAL TISSUE; ENDOCARDIUM; ENDOTHELIUM CELL; GATA4 GENE; GENE; GENE LOCUS; HEART DEVELOPMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; TRANSGENE;

EID: 84355166506     PISSN: 00121606     EISSN: 1095564X     Source Type: Journal    
DOI: 10.1016/j.ydbio.2011.10.023     Document Type: Article

References (84)

1. Altschul S.F., Gish W., Miller W., Myers E.W., Lipman D.J. Basic local alignment search tool. J. Mol. Biol. 1990, 215:403-410.
2. Anderson J.P., Dodou E., Heidt A.B., De Val S.J., Jaehnig E.J., Greene S.B., Olson E.N., Black B.L. HRC is a direct transcriptional target of MEF2 during cardiac, skeletal, and arterial smooth muscle development in vivo. Mol. Cell. Biol. 2004, 24:3757-3768.
3. Andries L.J., Brutsaert D.L. Endocardial endothelium in the rat: cell shape and organization of the cytoskeleton. Cell Tissue Res. 1993, 273:107-117.
4. Arber S., Ladle D.R., Lin J.H., Frank E., Jessell T.M. ETS gene Er81 controls the formation of functional connections between group Ia sensory afferents and motor neurons. Cell 2000, 101:485-498.
5. Arceci R.J., King A.A., Simon M.C., Orkin S.H., Wilson D.B. Mouse GATA-4: a retinoic acid-inducible GATA-binding transcription factor expressed in endodermally derived tissues and heart. Mol. Cell. Biol. 1993, 13:2235-2246.
6. Barton K., Muthusamy N., Fischer C., Ting C.N., Walunas T.L., Lanier L.L., Leiden J.M. The Ets-1 transcription factor is required for the development of natural killer cells in mice. Immunity 1998, 9:555-563.
7. Blow M.J., McCulley D.J., Li Z., Zhang T., Akiyama J.A., Holt A., Plajzer-Frick I., Shoukry M., Wright C., Chen F., Afzal V., Bristow J., Ren B., Black B.L., Rubin E.M., Visel A., Pennacchio L.A. ChIP-Seq identification of weakly conserved heart enhancers. Nat. Genet. 2010, 42:806-810.
8. Brand T. Heart development: molecular insights into cardiac specification and early morphogenesis. Dev. Biol. 2003, 258:1-19.
9. Bruneau B.G. The developmental genetics of congenital heart disease. Nature 2008, 451:943-948.
10. Brutsaert D.L., Andries L.J. The endocardial endothelium. Am. J. Physiol. 1992, 263:H985-H1002.
11. Butler T.L., Esposito G., Blue G.M., Cole A.D., Costa M.W., Waddell L.B., Walizada G., Sholler G.F., Kirk E.P., Feneley M., Harvey R.P., Winlaw D.S. GATA4 mutations in 357 unrelated patients with congenital heart malformation. Genet. Test. Mol. Biomarkers 2010, 14:797-802.
12. Charron F., Nemer M. GATA transcription factors and cardiac development. Semin. Cell Dev. Biol. 1999, 10:85-91.
13. Combs M.D., Yutzey K.E. Heart valve development: regulatory networks in development and disease. Circ. Res. 2009, 105:408-421.
14. De Val S., Black B.L. Transcriptional control of endothelial cell development. Dev. Cell 2009, 16:180-195.
15. De Val S., Anderson J.P., Heidt A.B., Khiem D., Xu S.M., Black B.L. Mef2c is activated directly by Ets transcription factors through an evolutionarily conserved endothelial cell-specific enhancer. Dev. Biol. 2004, 275:424-434.
16. De Val S., Chi N.C., Meadows S.M., Minovitsky S., Anderson J.P., Harris I.S., Ehlers M.L., Agarwal P., Visel A., Xu S.M., Pennacchio L.A., Dubchak I., Krieg P.A., Stainier D.Y., Black B.L. Combinatorial regulation of endothelial gene expression by ets and forkhead transcription factors. Cell 2008, 135:1053-1064.
17. Dodou E., Xu S.M., Black B.L. mef2c is activated directly by myogenic basic helix-loop-helix proteins during skeletal muscle development in vivo. Mech. Dev. 2003, 120:1021-1032.
18. Dodou E., Verzi M.P., Anderson J.P., Xu S.M., Black B.L. Mef2c is a direct transcriptional target of ISL1 and GATA factors in the anterior heart field during mouse embryonic development. Development 2004, 131:3931-3942.
19. Downs K.M., Gifford S., Blahnik M., Gardner R.L. Vascularization in the murine allantois occurs by vasculogenesis without accompanying erythropoiesis. Development 1998, 125:4507-4520.
20. Drake C.J., Fleming P.A. Vasculogenesis in the day 6.5 to 9.5 mouse embryo. Blood 2000, 95:1671-1679.
21. Fehling H.J., Lacaud G., Kubo A., Kennedy M., Robertson S., Keller G., Kouskoff V. Tracking mesoderm induction and its specification to the hemangioblast during embryonic stem cell differentiation. Development 2003, 130:4217-4227.
22. Flamme I., Frolich T., Risau W. Molecular mechanisms of vasculogenesis and embryonic angiogenesis. J. Cell. Physiol. 1997, 173:206-210.
23. Galang C.K., Muller W.J., Foos G., Oshima R.G., Hauser C.A. Changes in the expression of many Ets family transcription factors and of potential target genes in normal mammary tissue and tumors. J. Biol. Chem. 2004, 279:11281-11292.
24. Gao Z., Kim G.H., Mackinnon A.C., Flagg A.E., Bassett B., Earley J.U., Svensson E.C. Ets1 is required for proper migration and differentiation of the cardiac neural crest. Development 2010, 137:1543-1551.
25. Garg V., Kathiriya I.S., Barnes R., Schluterman M.K., King I.N., Butler C.A., Rothrock C.R., Eapen R.S., Hirayama-Yamada K., Joo K., Matsuoka R., Cohen J.C., Srivastava D. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature 2003, 424:443-447.
26. Garrett-Sinha L.A., Dahl R., Rao S., Barton K.P., Simon M.C. PU.1 exhibits partial functional redundancy with Spi-B, but not with Ets-1 or Elf-1. Blood 2001, 97:2908-2912.
27. Gory S., Dalmon J., Prandini M.H., Kortulewski T., de Launoit Y., Huber P. Requirement of a GT box (Sp1 site) and two Ets binding sites for vascular endothelial cadherin gene transcription. J. Biol. Chem. 1998, 273:6750-6755.
28. Graves B.J., Petersen J.M. Specificity within the ets family of transcription factors. Adv. Cancer Res. 1998, 75:1-55.
29. Harris I.S., Black B.L. Development of the endocardium. Pediatr. Cardiol. 2010, 31:391-399.
30. Hashiya N., Jo N., Aoki M., Matsumoto K., Nakamura T., Sato Y., Ogata N., Ogihara T., Kaneda Y., Morishita R. In vivo evidence of angiogenesis induced by transcription factor Ets-1: Ets-1 is located upstream of angiogenesis cascade. Circulation 2004, 109:3035-3041.
31. He A., Kong S.W., Ma Q., Pu W.T. Co-occupancy by multiple cardiac transcription factors identifies transcriptional enhancers active in heart. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:5632-5637.
32. Hippenmeyer S., Huber R.M., Ladle D.R., Murphy K., Arber S. ETS transcription factor Erm controls subsynaptic gene expression in skeletal muscles. Neuron 2007, 55:726-740.
33. Hirayama-Yamada K., Kamisago M., Akimoto K., Aotsuka H., Nakamura Y., Tomita H., Furutani M., Imamura S., Takao A., Nakazawa M., Matsuoka R. Phenotypes with GATA4 or NKX2.5 mutations in familial atrial septal defect. Am. J. Med. Genet. A 2005, 135:47-52.
34. Hollenhorst P.C., Jones D.A., Graves B.J. Expression profiles frame the promoter specificity dilemma of the ETS family of transcription factors. Nucleic Acids Res. 2004, 32:5693-5702.
35. Hollenhorst P.C., McIntosh L.P., Graves B.J. Genomic and biochemical insights into the specificity of ETS transcription factors. Annu. Rev. Biochem. 2011, 80:437-471.
36. Hutson M.R., Kirby M.L. Model systems for the study of heart development and disease. Cardiac neural crest and conotruncal malformations. Semin. Cell Dev. Biol. 2007, 18:101-110.
37. Kattman S.J., Huber T.L., Keller G.M. Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev. Cell 2006, 11:723-732.
38. Kothary R., Clapoff S., Darling S., Perry M.D., Moran L.A., Rossant J. Inducible expression of an hsp68-lacZ hybrid gene in transgenic mice. Development 1989, 105:707-714.
39. Kouskoff V., Lacaud G., Schwantz S., Fehling H.J., Keller G. Sequential development of hematopoietic and cardiac mesoderm during embryonic stem cell differentiation. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:13170-13175.
40. Kuo C.T., Morrisey E.E., Anandappa R., Sigrist K., Lu M.M., Parmacek M.S., Soudais C., Leiden J.M. GATA4 transcription factor is required for ventral morphogenesis and heart tube formation. Genes Dev. 1997, 11:1048-1060.
41. Lee D., Park C., Lee H., Lugus J.J., Kim S.H., Arentson E., Chung Y.S., Gomez G., Kyba M., Lin S., Janknecht R., Lim D.S., Choi K. ER71 acts downstream of BMP, Notch, and Wnt signaling in blood and vessel progenitor specification. Cell Stem Cell 2008, 2:497-507.
42. Lepore J.J., Mericko P.A., Cheng L., Lu M.M., Morrisey E.E., Parmacek M.S. GATA-6 regulates semaphorin 3C and is required in cardiac neural crest for cardiovascular morphogenesis. J. Clin. Invest. 2006, 116:929-939.
43. Loughran S.J., Kruse E.A., Hacking D.F., de Graaf C.A., Hyland C.D., Willson T.A., Henley K.J., Ellis S., Voss A.K., Metcalf D., Hilton D.J., Alexander W.S., Kile B.T. The transcription factor Erg is essential for definitive hematopoiesis and the function of adult hematopoietic stem cells. Nat. Immunol. 2008, 9:810-819.
44. Lugus J.J., Chung Y.S., Mills J.C., Kim S.I., Grass J., Kyba M., Doherty J.M., Bresnick E.H., Choi K. GATA2 functions at multiple steps in hemangioblast development and differentiation. Development 2007, 134:393-405.
45. Markwald R.R., Norris R.A., Moreno-Rodriguez R., Levine R.A. Developmental basis of adult cardiovascular diseases: valvular heart diseases. Ann. N. Y. Acad. Sci. 2010, 1188:177-183.
46. Masino A.M., Gallardo T.D., Wilcox C.A., Olson E.N., Williams R.S., Garry D.J. Transcriptional regulation of cardiac progenitor cell populations. Circ. Res. 2004, 95:389-397.
47. Mayor C., Brudno M., Schwartz J.R., Poliakov A., Rubin E.M., Frazer K.A., Pachter L.S., Dubchak I. VISTA : visualizing global DNA sequence alignments of arbitrary length. Bioinformatics 2000, 16:1046-1047.
48. Melax H., Leeson T.S. Fine structure of the endocardium in adult rats. Cardiovasc. Res. 1967, 1:349-355.
49. Misfeldt A.M., Boyle S.C., Tompkins K.L., Bautch V.L., Labosky P.A., Baldwin H.S. Endocardial cells are a distinct endothelial lineage derived from Flk1+ multipotent cardiovascular progenitors. Dev. Biol. 2009, 333:78-89.
50. Molkentin J.D. The zinc finger-containing transcription factors GATA-4, -5, and -6. Ubiquitously expressed regulators of tissue-specific gene expression. J. Biol. Chem. 2000, 275:38949-38952.
51. Molkentin J.D., Lin Q., Duncan S.A., Olson E.N. Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis. Genes Dev. 1997, 11:1061-1072.
52. Moskowitz I.P., Wang J., Peterson M.A., Pu W.T., Mackinnon A.C., Oxburgh L., Chu G.C., Sarkar M., Berul C., Smoot L., Robertson E.J., Schwartz R., Seidman J.G., Seidman C.E. Cardiac-specific transcription factor genes Smad4 and Gata4 cooperatively regulate cardiac valve development. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:4006-4011.
53. Nikolova-Krstevski V., Yuan L., Le Bras A., Vijayaraj P., Kondo M., Gebauer I., Bhasin M., Carman C.V., Oettgen P. ERG is required for the differentiation of embryonic stem cells along the endothelial lineage. BMC Dev. Biol. 2009, 9:72.
54. Oka T., Maillet M., Watt A.J., Schwartz R.J., Aronow B.J., Duncan S.A., Molkentin J.D. Cardiac-specific deletion of Gata4 reveals its requirement for hypertrophy, compensation, and myocyte viability. Circ. Res. 2006, 98:837-845.
55. Patient R.K., McGhee J.D. The GATA family (vertebrates and invertebrates). Curr. Opin. Genet. Dev. 2002, 12:416-422.
56. Person A.D., Klewer S.E., Runyan R.B. Cell biology of cardiac cushion development. Int. Rev. Cytol. 2005, 243:287-335.
57. Pham V.N., Lawson N.D., Mugford J.W., Dye L., Castranova D., Lo B., Weinstein B.M. Combinatorial function of ETS transcription factors in the developing vasculature. Dev. Biol. 2007, 303:772-783.
58. Pimanda J.E., Ottersbach K., Knezevic K., Kinston S., Chan W.Y., Wilson N.K., Landry J.R., Wood A.D., Kolb-Kokocinski A., Green A.R., Tannahill D., Lacaud G., Kouskoff V., Gottgens B. Gata2, Fli1, and Scl form a recursively wired gene-regulatory circuit during early hematopoietic development. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:17692-17697.
59. Pimanda J.E., Chan W.Y., Wilson N.K., Smith A.M., Kinston S., Knezevic K., Janes M.E., Landry J.R., Kolb-Kokocinski A., Frampton J., Tannahill D., Ottersbach K., Follows G.A., Lacaud G., Kouskoff V., Gottgens B. Endoglin expression in blood and endothelium is differentially regulated by modular assembly of the Ets/Gata hemangioblast code. Blood 2008, 112:4512-4522.
60. Ristevski S., O'Leary D.A., Thornell A.P., Owen M.J., Kola I., Hertzog P.J. The ETS transcription factor GABPalpha is essential for early embryogenesis. Mol. Cell. Biol. 2004, 24:5844-5849.
61. Rivera-Feliciano J., Lee K.H., Kong S.W., Rajagopal S., Ma Q., Springer Z., Izumo S., Tabin C.J., Pu W.T. Development of heart valves requires Gata4 expression in endothelial-derived cells. Development 2006, 133:3607-3618.
62. Rojas A., De Val S., Heidt A.B., Xu S.M., Bristow J., Black B.L. Gata4 expression in lateral mesoderm is downstream of BMP4 and is activated directly by Forkhead and GATA transcription factors through a distal enhancer element. Development 2005, 132:3405-3417.
63. Rojas A., Kong S.W., Agarwal P., Gilliss B., Pu W.T., Black B.L. GATA4 is a direct transcriptional activator of cyclin D2 and Cdk4 and is required for cardiomyocyte proliferation in anterior heart field-derived myocardium. Mol. Cell. Biol. 2008, 28:5420-5431.
64. Rojas A., Schachterle W., Xu S.M., Black B.L. An endoderm-specific transcriptional enhancer from the mouse Gata4 gene requires GATA and homeodomain protein-binding sites for function in vivo. Dev. Dyn. 2009, 238:2588-2598.
65. Rojas A., Schachterle W., Xu S.M., Martin F., Black B.L. Direct transcriptional regulation of Gata4 during early endoderm specification is controlled by FoxA2 binding to an intronic enhancer. Dev. Biol. 2010, 346:346-355.
66. Ronicke V., Risau W., Breier G. Characterization of the endothelium-specific murine vascular endothelial growth factor receptor-2 (Flk-1) promoter. Circ. Res. 1996, 79:277-285.
67. Sato Y. Role of ETS family transcription factors in vascular development and angiogenesis. Cell Struct. Funct. 2001, 26:19-24.
68. Schlaeger T.M., Bartunkova S., Lawitts J.A., Teichmann G., Risau W., Deutsch U., Sato T.N. Uniform vascular-endothelial-cell-specific gene expression in both embryonic and adult transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:3058-3063.
69. Schluterman M.K., Krysiak A.E., Kathiriya I.S., Abate N., Chandalia M., Srivastava D., Garg V. Screening and biochemical analysis of GATA4 sequence variations identified in patients with congenital heart disease. Am. J. Med. Genet. A 2007, 143A:817-823.
70. Snarr B.S., Kern C.B., Wessels A. Origin and fate of cardiac mesenchyme. Dev. Dyn. 2008, 237:2804-2819.
71. Song H., Suehiro J., Kanki Y., Kawai Y., Inoue K., Daida H., Yano K., Ohhashi T., Oettgen P., Aird W.C., Kodama T., Minami T. Critical role for GATA3 in mediating Tie2 expression and function in large vessel endothelial cells. J. Biol. Chem. 2009, 284:29109-29124.
72. Spyropoulos D.D., Pharr P.N., Lavenburg K.R., Jackers P., Papas T.S., Ogawa M., Watson D.K. Hemorrhage, impaired hematopoiesis, and lethality in mouse embryos carrying a targeted disruption of the Fli1 transcription factor. Mol. Cell. Biol. 2000, 20:5643-5652.
73. Stankunas K., Hang C.T., Tsun Z.Y., Chen H., Lee N.V., Wu J.I., Shang C., Bayle J.H., Shou W., Iruela-Arispe M.L., Chang C.P. Endocardial Brg1 represses ADAMTS1 to maintain the microenvironment for myocardial morphogenesis. Dev. Cell 2008, 14:298-311.
74. Taoudi S., Bee T., Hilton A., Knezevic K., Scott J., Willson T.A., Collin C., Thomas T., Voss A.K., Kile B.T., Alexander W.S., Pimanda J.E., Hilton D.J. ERG dependence distinguishes developmental control of hematopoietic stem cell maintenance from hematopoietic specification. Genes Dev. 2011, 25:251-262.
75. Visel A., Blow M.J., Li Z., Zhang T., Akiyama J.A., Holt A., Plajzer-Frick I., Shoukry M., Wright C., Chen F., Afzal V., Ren B., Rubin E.M., Pennacchio L.A. ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature 2009, 457:854-858.
76. Wagner M., Siddiqui M.A. Signal transduction in early heart development (II): ventricular chamber specification, trabeculation, and heart valve formation. Exp. Biol. Med. (Maywood) 2007, 232:866-880.
77. Wang L.C., Kuo F., Fujiwara Y., Gilliland D.G., Golub T.R., Orkin S.H. Yolk sac angiogenic defect and intra-embryonic apoptosis in mice lacking the Ets-related factor TEL. EMBO J. 1997, 16:4374-4383.
78. Wei G., Srinivasan R., Cantemir-Stone C.Z., Sharma S.M., Santhanam R., Weinstein M., Muthusamy N., Man A.K., Oshima R.G., Leone G., Ostrowski M.C. Ets1 and Ets2 are required for endothelial cell survival during embryonic angiogenesis. Blood 2009, 114:1123-1130.
79. Xin M., Davis C.A., Molkentin J.D., Lien C.L., Duncan S.A., Richardson J.A., Olson E.N. A threshold of GATA4 and GATA6 expression is required for cardiovascular development. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:11189-11194.
80. Ye M., Coldren C., Liang X., Mattina T., Goldmuntz E., Benson D.W., Ivy D., Perryman M.B., Garrett-Sinha L.A., Grossfeld P. Deletion of ETS-1, a gene in the Jacobsen syndrome critical region, causes ventricular septal defects and abnormal ventricular morphology in mice. Hum. Mol. Genet. 2010, 19:648-656.
81. Yuan L., Sacharidou A., Stratman A.N., Le Bras A., Zwiers P.J., Spokes K., Bhasin M., Shih S.C., Nagy J.A., Molema G., Aird W.C., Davis G.E., Oettgen P. RhoJ is an endothelial cellrestricted Rho GTPase that mediates vascular morphogenesis and is regulated by the transcription factor ERG. Blood 2011, 118:1145-1153.
82. Zeisberg E.M., Ma Q., Juraszek A.L., Moses K., Schwartz R.J., Izumo S., Pu W.T. Morphogenesis of the right ventricle requires myocardial expression of Gata4. J. Clin. Invest. 2005, 115:1522-1531.
83. Zhang W., Li X., Shen A., Jiao W., Guan X., Li Z. GATA4 mutations in 486 Chinese patients with congenital heart disease. Eur. J. Med. Genet. 2008, 51:527-535.
84. Zhao R., Watt A.J., Battle M.A., Li J., Bondow B.J., Duncan S.A. Loss of both GATA4 and GATA6 blocks cardiac myocyte differentiation and results in acardia in mice. Dev. Biol. 2008, 317:614-619.